Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594222 | SCV000708666 | uncertain significance | not provided | 2018-01-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532643 | SCV003249357 | likely benign | Alpha-1-antitrypsin deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003392441 | SCV004119960 | uncertain significance | SERPINA1-related disorder | 2023-10-11 | criteria provided, single submitter | clinical testing | The SERPINA1 c.879C>A variant is predicted to result in the amino acid substitution p.His293Gln. This variant has been reported in a study of heavy smokers with emphysema or chronic obstructive lung disease (Ortega et al. 2020. PubMed ID: 31661293) and in an adult patient with hepatic cytolysis, cholestasis and cirrhosis of the liver (Renoux et al. 2018. PubMed ID: 30223862). This variant is reported in 0.18% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |